CLINAM has created the European Journal of Nanomedicine (de Gruyter, Berlin). Prof. Patrick Hunziker and Prof. Jan Mollenhauer are the Editors-in-Chief; Dr. Beat Löffler and Dr. Georgette B Salieb-Beugelaar are the Scientific and Managing Editors of CLINAM. The European Journal of Nanomedicine (EUJNM - http://www.degruyter.com/view/j/ejnm) focuses on fields ranging from nano(bio)technological engineering and characterization to clinically translatable innovative prevention, diagnostics, and therapies for major and neglected human diseases. The readership is thus multidisciplinary, including scientists in chemistry, physics, engineering, pharmacology, molecular biology, biomedicine, and clinicians. The journal is aimed at people in academic, industrial, and regulatory environments, as well as the informed public and policymakers. The main topics covered are Experimental, Analytical, (Pre-) Clinical, Preventive and Therapeutic Nanomedicine, Nanomaterials, Nanobiotechnology, Nanodiagnostics, Nontoxicity, Nano-Imaging Technologies, Vanguard Nano-Technologies, Implementation and Implications of Nano-medicine, and Personalized Nanomedicine.